Holly Shelton

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Vaccination, Vaccine Safety, Phase 1/2 +7

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen et al. · Nature Communications · 2021 · 283 citations · Full text

The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins

Carina Conceicao, Nazia Thakur, Stacey Human et al. · PLoS Biology · 2020 · 218 citations · Full text

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19

Simon P. Graham, Rebecca McLean, Alexandra J. Spencer et al. · npj Vaccines · 2020 · 145 citations · Full text

Species specific differences in use of ANP32 proteins by influenza A virus

Jason S. Long, Alewo Idoko-Akoh, Bhakti Mistry et al. · eLife · 2019 · 101 citations · Full text

Viral Replication, Synthetic Virology, Immunology +17